Navigation Links
New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry
Date:4/22/2013

model must evolve to adequately and effectively meet the challenges of a constantly changing regulatory environment. When asked about the vision for the next-generation of Strategic Partnerships, the respondents identified increased alignment in commercial incentives, deeper team collaboration (strategic and targeted expertise) and faster time-to-market through improved cycle times as the top three areas. 

Later this week at the Annual Partnerships conference (Wednesday, April 24), Mr. von Rickenbach will serve as a panelist at a session/roundtable titled, "Wall Street Leadership Panel on the Economic Outlook for Pharma in 2013 - Opportunities, Investment Areas and Effects on the Outsourcing Industry."  As part of his presentation, he will discuss the benefits and implications of Strategic Partnerships based on PAREXEL's experience, and the CRO industry's future outlook.

About Strategic Partnerships 2013
For the report, Booms Research & Consulting, Inc. - an independent research firm conducted in-depth interviews among senior-level executives such as C-suite leaders as well as heads of clinical operations, R&D, and strategic outsourcing, representing global biopharmaceutical companies (n=26). The sample size included: 71% large pharmaceutical companies, 12% mid-sized pharmaceutical companies, and 17% small biopharmaceutical companies. The interviews were conducted in English in the fall 2012. Participants represent companies with 39% of industry R&D spend. The report included both quantitative and qualitative questions to better understand the current state of clinical development outsourcing and strategic partnerships. The survey includes both single and multiple response questions. As such, some percentages will exceed 100%.

For a full copy of the report, please visit

SOURCE PAREXEL International
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PAREXEL International Provides Update On Share Repurchase Program, Announces A New $50 Million Accelerated Share Repurchase Agreement And A New $50 Million 10b5-1 Trading Plan
2. PAREXEL International To Present At Raymond James Investors Conference And Barclays Capital Healthcare Conference
3. PAREXEL International To Present At Citi Global Healthcare Conference
4. PAREXEL International Reports Second Quarter Fiscal Year 2013 Results
5. PAREXEL International To Present At Oppenheimer Healthcare Conference
6. PAREXEL International To Present At Lazard Capital Healthcare Conference And Jefferies Global Healthcare Conference
7. PAREXEL and Salem State University Launch Clinical Trial Management Graduate Program
8. PAREXEL International to Present at Robert Baird Healthcare Conference
9. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
10. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
11. PAREXEL And Korea Drug Development Fund Announce Alliance To Accelerate Global Drug Development And Commercialization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... LONDON , December 24, 2014 ... to grow at an average rate of 8.1%. The ... volume. Hip, knee and spine surgeries are the common ... economies they have a lower penetration. Increased number of ... of composites. Non-metallic orthopedic devices have gained popularity in ...
(Date:12/24/2014)... 23, 2014  Advanced Medical Isotope Corporation ("AMIC") ... in the development of brachytherapy devices and medical ... that it has filed a de novo ... ("FDA") for marketing clearance for its patented Y-90 ... U.S. Food, Drug and Cosmetic Act (the "Act").  ...
(Date:12/24/2014)... , Dec. 23, 2014   Synageva BioPharma ... biopharmaceutical company developing therapeutic products for rare disorders, ... (EMA) of the Marketing Authorization Application (MAA) for ... granted the company,s request for accelerated assessment, which ... review time.   The MAA, and ...
Breaking Medicine Technology:Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3
...   ConvaTec, a world-leading developer and marketer of ... announced that it has acquired AbViser Medical, LLC (formerly ... City, UT-based company that specializes in products for the ... (IAP) Monitoring System enables clinicians to measure and monitor ...
... 1, 2012  Solta Medical, Inc. (NASDAQ: SLTM ), ... results for the first quarter ended March 31, 2012. Revenue ... $6.0 million, or 23%, as compared to the first quarter ... system, was $7.6 million, which was generated from sales of ...
Cached Medicine Technology:ConvaTec Announces Acquisition of AbViser Medical, LLC 2Solta Medical Reports First Quarter Results 2Solta Medical Reports First Quarter Results 3Solta Medical Reports First Quarter Results 4Solta Medical Reports First Quarter Results 5Solta Medical Reports First Quarter Results 6Solta Medical Reports First Quarter Results 7Solta Medical Reports First Quarter Results 8
(Date:12/26/2014)... 26, 2014 DW-InductionHeating.com (DaWei Induction Heating ... researching and developing, producing and marketing of a series ... business announces their new series of induction brazing ... the company, induction brazing refers to the ... filler material and heat. The manager says that there ...
(Date:12/25/2014)... December 26, 2014 The microscopy ... of 7.2% to reach $5,756.0 million by 2019. ... microscopy market. The electron microscopes product segment is ... forecast period. , Rising focus on nanotechnology, technological ... of the microscopy market. , Get Full Copy ...
(Date:12/25/2014)... The click strand woven bamboo ... durability. Today, the business announces a click strand ... Jan. 30, 2015. , Click strand woven bamboo ... is a well-known brand in the bamboo industry. ... a reliable bamboo flooring supplier. , “We are ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 The ... to 2023” focuses on the current treatment landscape, unmet ... cancer market. TS-1 is an anti-cancer drug which is ... orally and is also used for treating gastric cancer ... and otastat potassium. The drug was first approved in ...
(Date:12/25/2014)... “Every three months the trends for ... evening dress will be one of the hottest styles in ... says. Today, the company releases 26 A-line sweetheart evening dresses, ... off. , “We are trying our best to help ... latest designs. Along with affordable prices, we provide discounted delivery ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3
... Dec. 6 - Atlantic Information,Services, Inc. (AIS) -- ... Benefit News and Specialty Pharmacy News has just,released ... For the,past eight years, AIS has been surveying ... the results to track trends in this,volatile industry. ...
... do you get for the nut,that has everything, including more ... Chuck talking therapy doll?, You can at once give ... needs it, their own personal and portable psychotherapist. The,Ask Doctor ... which could,earn you the undying gratitude of the rest of ...
... ALISO VIEJO, Calif., Dec. 6 Clarient, Inc.,(Nasdaq: ... resource for,pathologists, oncologists and the pharmaceutical industry, today ... in a panel discussion,titled "From Discovery To Diagnosis: ... Capital Markets 2007 Healthcare Conference at 3:30 p.m.,EST ...
... Unveiled in Ongoing Preparation for Commercial Launch, ... Inc. (Nasdaq:,FVRL), a biopharmaceutical company developing patient-specific, ... that new data,including four-year follow-up data from ... (formerly FavId(R)), will be reported in four,separate ...
... and OMX Nordic Exchange: EPCT) today announced that ... overview at the New York Society,of Security Analysts ... December 12, 2007 at 4:05 p.m. Eastern Time. ... at 1177 Avenue of the Americas in,New York ...
... Be Presented at 2008 Convention, BALTIMORE, Dec. ... launched the Dr. Jacob Bolotin Award Program. Beginning ... present cash awards to,individuals and organizations that have ... the blind into society on a basis,of equality., ...
Cached Medicine News:Health News:2000-2007 Pharmacy Benefit Survey Results Just Released 2Health News:The Cure for Holiday Stress 2Health News:Clarient CEO Andrews to Participate in Panel Discussion at the RBC Capital Markets 2007 Healthcare Conference 2Health News:Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting 2Health News:Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting 3Health News:Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting 4Health News:Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting 5Health News:EpiCept Corporation to Present at The New York Society of Security Analysts 11th Annual Biotech & Specialty Pharma Conference 2Health News:EpiCept Corporation to Present at The New York Society of Security Analysts 11th Annual Biotech & Specialty Pharma Conference 3Health News:National Federation of the Blind to Award $100,000 2
... Accu-Temp Cauteries provide a broad selection ... a wide variety of ophthalmic procedures. ... sterile, complete with a safety cap ... " position when not in use, ...
... a broad selection of tip styles ... of ophthalmic procedures. Each single use ... a safety cap to lock switch ... not in use, and carries a ...
... provide the surgeon with an indirect illumination ... be easily visualized through the laser microscope. ... light scatter technique, the surgeon can enhance ... edge folds, corneal flap striae and flap ...
... system allows you access to the most ... system includes 10 different optotypes, crowding bars, ... characters. Random character sequencing eliminates memorization. In ... line and multiple line selection capability. The ...
Medicine Products: